Should you buy Cash Converters International Ltd on today's news?

Cash Converters International Ltd (ASX:CCV) announces a strong first quarter.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cash Converters International Ltd (ASX: CCV) announced a net profit after tax (NPAT) of $6.3 million for the first quarter of 2017. It also confirmed its previous NPAT guidance of $20 million to $23 million for the full year. The market barely responded to the news, with shares trading down 2% this afternoon.

The company has had a torrid time of it of late with class actions and compliance issues related to its lending practices hurting profitability and the share price. The stock has sunk 73% since peaking at $1.46 in early 2013.

The company is in the process of transitioning its UK division to franchise only and shrinking its Small Account Credit Contract (SACC) loan book. Its SACC business has caused most of the regulatory headaches endured over recent years and both these moves should reduce lending risk.

Like listed peers FSA Group Ltd (ASX: FSA) and Money3 Corporation Limited (ASX: MNY), Cash Converters is looking to grow its automotive finance arm. The company hopes that this will fill the void left by the shrinking SACC segment.

At the midpoint of 2017 guidance, Cash Converters is trading on a price-to-earnings ratio (PER) of 8. At these levels, zero growth is required for the stock to be decent investment as the dividend alone is worth 12% when grossed up. Of course, this also assumes things don't deteriorate from here.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »